|
US3145209A
(en)
|
1961-07-31 |
1964-08-18 |
Olin Mathieson |
Substituted aminophenyl-ethylamine derivatives
|
|
US3975443A
(en)
|
1972-06-06 |
1976-08-17 |
Allen & Hanburys Limited |
1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine
|
|
DE3718317A1
(de)
|
1986-12-10 |
1988-06-16 |
Bayer Ag |
Substituierte basische 2-aminotetraline
|
|
US5032604A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
|
DE4302051A1
(de)
|
1993-01-26 |
1994-07-28 |
Thomae Gmbh Dr K |
5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
ATE166650T1
(de)
|
1993-03-04 |
1998-06-15 |
Pfizer |
Spiroazacyclischderivate als substanz p antagonisten
|
|
ATE216580T1
(de)
|
1993-07-16 |
2002-05-15 |
Merck & Co Inc |
Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten
|
|
US5464788A
(en)
|
1994-03-24 |
1995-11-07 |
Merck & Co., Inc. |
Tocolytic oxytocin receptor antagonists
|
|
RU2149872C1
(ru)
|
1994-07-20 |
2000-05-27 |
Бык Гульден Ломберг Хемише Фабрик Гмбх |
Пиридилтиосоединения для борьбы с бактериями helicobacter
|
|
FR2731222A1
(fr)
|
1995-03-02 |
1996-09-06 |
Pf Medicament |
Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments
|
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5939418A
(en)
|
1995-12-21 |
1999-08-17 |
The Dupont Merck Pharmaceutical Company |
Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors
|
|
DE19548624A1
(de)
|
1995-12-23 |
1997-06-26 |
Boehringer Mannheim Gmbh |
Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US6333322B1
(en)
|
1996-03-13 |
2001-12-25 |
Eisai Co., Ltd. |
Nitrogen-containing tricyclic compounds and drugs containing the same
|
|
US5885995A
(en)
|
1996-04-03 |
1999-03-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2250587A1
(en)
|
1996-04-03 |
1997-10-09 |
Christopher J. Dinsmore |
Inhibitors of farnesyl-protein transferase
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5859012A
(en)
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
EP0904080A4
(en)
|
1996-04-03 |
2001-08-01 |
Merck & Co Inc |
INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
|
|
DE19700431A1
(de)
|
1997-01-10 |
1998-07-16 |
Basf Ag |
Reaktivfarbstoffe mit einem Disulfonylanker
|
|
US6060038A
(en)
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
|
WO1999040075A1
(en)
|
1998-02-05 |
1999-08-12 |
Takeda Chemical Industries, Ltd. |
Sulfonamide derivatives, process for producing the same and utilization thereof
|
|
GB9806287D0
(en)
|
1998-03-24 |
1998-05-20 |
Synphar Lab Inc |
Monobactam enzyme inhibitors
|
|
TWI220143B
(en)
|
1998-05-13 |
2004-08-11 |
Solvay Pharm Gmbh |
Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products
|
|
CA2332239A1
(en)
|
1998-05-15 |
1999-11-25 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds which inhibit parp activity
|
|
US6380193B1
(en)
|
1998-05-15 |
2002-04-30 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
|
|
US6509338B1
(en)
|
1998-06-22 |
2003-01-21 |
Bristol-Myers Squibb Company |
Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
|
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
|
WO2000042852A1
(en)
|
1999-01-25 |
2000-07-27 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
CA2363169A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
US6355643B1
(en)
|
1999-03-03 |
2002-03-12 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
CA2362493A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
WO2000051614A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferases
|
|
CA2362778A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
DE19911510A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
AU5464200A
(en)
|
1999-06-09 |
2000-12-28 |
Merck & Co., Inc. |
Biaryl inhibitors of prenyl-protein transferase
|
|
US6642228B1
(en)
|
1999-06-24 |
2003-11-04 |
Toray Industries, Inc. |
α1b-adrenergic receptor antagonists
|
|
WO2001014331A2
(en)
|
1999-08-24 |
2001-03-01 |
Regents Of The University Of California |
Non-quinoline inhibitors of malaria parasites
|
|
DE19944066A1
(de)
|
1999-09-14 |
2001-03-15 |
Byk Gulden Lomberg Chem Fab |
Inhibitoren der Tryptase
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
KR20010087401A
(ko)
|
1999-09-28 |
2001-09-15 |
스타르크, 카르크 |
아제피노인돌 유도체, 그의 제법 및 용도
|
|
US20020010184A1
(en)
|
2000-02-18 |
2002-01-24 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US20020052380A1
(en)
|
2000-02-18 |
2002-05-02 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
AU5144201A
(en)
|
2000-04-10 |
2001-10-23 |
Merck & Co Inc |
Inhibitors of prenyl-protein transferase
|
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1322643A1
(en)
|
2000-09-29 |
2003-07-02 |
Millennium Pharmaceuticals, Inc. |
Piperazin-2-one amides as inhibitors of factor xa
|
|
US20020115606A1
(en)
|
2000-10-17 |
2002-08-22 |
Myriad Genetics, Inc. |
Protein-protein interactions in neurodegenerative diseases
|
|
WO2002051836A1
(en)
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
|
SE0100902D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
US20030158209A1
(en)
|
2001-10-09 |
2003-08-21 |
Neurocrine Biosciences Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
WO2003053940A1
(en)
|
2001-12-20 |
2003-07-03 |
Bristol-Myers Squibb Company |
Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
|
|
AU2002357312A1
(en)
|
2001-12-20 |
2003-07-09 |
Bristol-Myers Squibb Company |
Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
|
|
WO2003061660A1
(en)
|
2002-01-23 |
2003-07-31 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
CA2479906C
(en)
|
2002-04-03 |
2011-02-08 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
|
|
NZ535764A
(en)
|
2002-04-18 |
2007-10-26 |
Schering Corp |
1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
|
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
MXPA04010555A
(es)
|
2002-04-25 |
2005-02-17 |
Pharmacia Corp |
Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
|
|
US20050209278A1
(en)
|
2002-04-25 |
2005-09-22 |
Mcdonald Joseph J |
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
WO2004000831A1
(en)
|
2002-06-24 |
2003-12-31 |
Schering Corporation |
Indole derivatives useful as histamine h3 antagonists
|
|
US6906096B2
(en)
|
2002-06-28 |
2005-06-14 |
Irm Llc |
4,7-Disubstituted indoles and methods of making
|
|
AU2003259131A1
(en)
|
2002-07-09 |
2004-01-23 |
Bristol-Myers Squibb Company |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
|
|
AU2003256922A1
(en)
|
2002-07-31 |
2004-02-16 |
Smithkline Beecham Corporation |
Substituted heterocyclic compounds as modulators of the ccr5 receptor
|
|
ES2399047T3
(es)
|
2002-09-20 |
2013-03-25 |
Merck Serono Sa |
Derivados de piperazina y procedimiento de uso
|
|
WO2004037817A1
(ja)
|
2002-10-25 |
2004-05-06 |
Mitsubishi Pharma Corporation |
Ｎ−オキシド化合物
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
US20050043533A1
(en)
|
2003-03-25 |
2005-02-24 |
Babiak Kevin A. |
Process for making alpha-substituted hydroxamic acids
|
|
WO2004099179A1
(en)
|
2003-05-07 |
2004-11-18 |
Actelion Pharmaceuticals Ltd |
Piperazine-alkyl-ureido derivatives
|
|
DE602004022819D1
(de)
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
|
AU2004271741A1
(en)
*
|
2003-09-12 |
2005-03-24 |
Laboratoires Serono Sa |
Sulfonamide derivatives for the treatment of diabetes
|
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
GB0328900D0
(en)
|
2003-12-12 |
2004-01-14 |
Glaxo Group Ltd |
Novel compounds
|
|
JP4769082B2
(ja)
|
2003-12-17 |
2011-09-07 |
武田薬品工業株式会社 |
ウレア誘導体、その製造法及び用途
|
|
JP2007515490A
(ja)
|
2003-12-22 |
2007-06-14 |
アムジェン インコーポレーティッド |
アリールスルホンアミド化合物およびそれに関連する使用法
|
|
JP2005232306A
(ja)
|
2004-02-19 |
2005-09-02 |
Fuji Photo Film Co Ltd |
光重合性組成物及びそれを用いた記録材料
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
WO2005087765A1
(en)
|
2004-03-04 |
2005-09-22 |
Arena Pharmaceuticals, Inc. |
Ligands of follicle stimulating hormone receptor and methods of use thereof
|
|
US20050197336A1
(en)
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
|
CA2559285A1
(en)
|
2004-03-18 |
2005-09-29 |
Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies
|
|
SE0400850D0
(sv)
|
2004-03-30 |
2004-03-31 |
Astrazeneca Ab |
Novel Compounds
|
|
US7345043B2
(en)
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
|
WO2005117882A2
(en)
|
2004-04-20 |
2005-12-15 |
Incyte Corporation |
Hydroxamic acid derivatives as metalloprotease inhibitors
|
|
GB0408777D0
(en)
*
|
2004-04-20 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
ES2346665T3
(es)
|
2004-05-07 |
2010-10-19 |
Warner-Lambert Company Llc |
Derivados de fenol y tiofenol 3- o 4-monosustituidos utiles como ligandos de h3.
|
|
US20090105218A1
(en)
|
2004-05-29 |
2009-04-23 |
7Tm Pharma A/S |
CRTH2 Receptor Ligands For Therapeutic Use
|
|
MXPA06013675A
(es)
|
2004-06-08 |
2007-02-13 |
Pfizer Prod Inc |
Antagonistas de nk1.
|
|
US20060241118A1
(en)
|
2004-06-18 |
2006-10-26 |
Celltech R&D Limited |
Hydroxamate sulfonamides as cd23 shedding inhibitors
|
|
CA2571824A1
(en)
|
2004-07-01 |
2006-01-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
WO2006008644A1
(en)
|
2004-07-13 |
2006-01-26 |
Pfizer Products Inc. |
Antidiabetic compounds
|
|
EP1781670A1
(en)
|
2004-07-22 |
2007-05-09 |
Cumbre Pharmaceuticals Inc. |
Rifamycin derivatives for treating microbial infections
|
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
PE20060653A1
(es)
|
2004-08-31 |
2006-09-27 |
Glaxo Group Ltd |
Derivados triciclicos condensados como moduladores del receptor 5-ht1
|
|
JP5080256B2
(ja)
|
2004-09-20 |
2012-11-21 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用
|
|
EP1807085B1
(en)
|
2004-09-20 |
2013-08-21 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
EP2289510A1
(en)
|
2004-09-20 |
2011-03-02 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
|
CA2588285A1
(en)
|
2004-11-29 |
2006-06-01 |
National University Corporation Nagoya University |
Glycopeptide antibiotic monomer derivatives
|
|
HRP20090264T1
(hr)
*
|
2004-12-09 |
2009-06-30 |
F. Hoffmann - La Roche Ag |
Derivati fenil-piperazin metanona
|
|
PE20061156A1
(es)
|
2004-12-23 |
2006-12-16 |
Glaxo Group Ltd |
Derivados de benzamida como agentes inhibidores del transportador de glicina
|
|
PE20061330A1
(es)
|
2004-12-23 |
2006-12-27 |
Glaxo Group Ltd |
Compuestos derivados de benzamida como inhibidores del transportador de glicina
|
|
GB0428233D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
GB0428232D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
JP2008525398A
(ja)
|
2004-12-23 |
2008-07-17 |
グラクソ グループ リミテッド |
グリシン輸送阻害剤
|
|
US7635698B2
(en)
|
2004-12-29 |
2009-12-22 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
US7880002B2
(en)
|
2004-12-29 |
2011-02-01 |
Millennium Pharmaceuticals, Inc. |
Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
|
|
AU2005324024B2
(en)
*
|
2005-01-07 |
2011-02-17 |
F. Hoffmann-La Roche Ag |
[4-(Heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
|
|
AU2006212951A1
(en)
|
2005-02-08 |
2006-08-17 |
Merck & Co., Inc. |
Inhibitors of checkpoint kinases
|
|
EP1866276A1
(en)
|
2005-03-21 |
2007-12-19 |
Celera Genomics |
Alpha ketoamide compounds as cysteine protease inhibitors
|
|
DE102005014936A1
(de)
|
2005-03-24 |
2006-12-14 |
Abbott Gmbh & Co. Kg |
Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
|
|
EP1866298A2
(en)
|
2005-03-31 |
2007-12-19 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
GB0510140D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
JP2008545760A
(ja)
|
2005-06-09 |
2008-12-18 |
メルク フロスト カナダ リミテツド |
ステアロイル−コエンザイムａデルタ−９デサチュラーゼのインヒビターとしてのアザシクロヘキサン誘導体
|
|
WO2006138218A1
(en)
|
2005-06-13 |
2006-12-28 |
Theravance, Inc. |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
EP1896453B1
(en)
|
2005-06-20 |
2009-12-02 |
Schering Corporation |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
|
|
DE602006010870D1
(de)
|
2005-06-20 |
2010-01-14 |
Schering Corp |
Als antagonisten von histamin h3 geeignete piperidinderivate
|
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
WO2007041025A2
(en)
*
|
2005-09-29 |
2007-04-12 |
Merck & Co., Inc. |
Radiolabeled glycine transporter inhibitors
|
|
EP1937659B1
(en)
*
|
2005-10-06 |
2010-11-10 |
Sanofi-Aventis |
Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
WO2007057742A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Novel piperazinone derivatives
|
|
US20070197505A1
(en)
|
2005-12-15 |
2007-08-23 |
Morgan Bradley P |
Certain chemical entities, compositions and methods
|
|
JP2009521448A
(ja)
|
2005-12-21 |
2009-06-04 |
シェーリング コーポレイション |
ヒスタミンｈ３アンタゴニストとして有用なフェノキシピペリジンおよびそのアナログ
|
|
MX2008008340A
(es)
|
2005-12-21 |
2008-09-03 |
Schering Corp |
Tratamiento de enfermedad de higado graso no alcoholica usando agentes reductores de colesterol y/o antagonista/agonista inverso de receptor de histamina 3.
|
|
US20070142369A1
(en)
|
2005-12-21 |
2007-06-21 |
Margaret Van Heek |
Combination of an H3 antagonist/inverse agonist and an appetite suppressant
|
|
MX2008008339A
(es)
|
2005-12-21 |
2008-09-03 |
Schering Corp |
Derivados de anilina sustituida ùtiles como antagonistas de la histamina h3.
|
|
US20070203111A1
(en)
|
2006-01-06 |
2007-08-30 |
Sepracor Inc. |
Cycloalkylamines as monoamine reuptake inhibitors
|
|
GB0600427D0
(en)
|
2006-01-10 |
2006-02-15 |
Glaxo Group Ltd |
Compounds
|
|
KR20080098490A
(ko)
|
2006-01-13 |
2008-11-10 |
파마시클릭스, 인코포레이티드 |
티로신 키나제 억제제 및 이의 용도
|
|
WO2007087220A2
(en)
|
2006-01-25 |
2007-08-02 |
The Trustees Of Columbia University In The City Of New York |
The total synthesis of ecteinascidin 743 and derivatives thereof
|
|
WO2007092435A2
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
11-beta hsd1 inhibitors
|
|
BRPI0707623A2
(pt)
|
2006-02-10 |
2011-05-10 |
Janssen Pharmaceutica Nv |
derivados de piperidina como antagonistas de receptores de cxcr3
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
JPWO2007119833A1
(ja)
|
2006-04-14 |
2009-08-27 |
武田薬品工業株式会社 |
含窒素複素環化合物
|
|
US8017612B2
(en)
|
2006-04-18 |
2011-09-13 |
Japan Tobacco Inc. |
Piperazine compound and use thereof as a HCV polymerase inhibitor
|
|
CA2650932C
(en)
|
2006-05-09 |
2013-01-22 |
Merck & Co., Inc. |
Substituted spirocyclic cgrp receptor antagonists
|
|
TW200808818A
(en)
|
2006-05-26 |
2008-02-16 |
Shionogi & Co |
Glycopeptide antibiotic derivatives
|
|
WO2007139150A1
(ja)
|
2006-05-30 |
2007-12-06 |
The University Of Tokushima |
ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤
|
|
EA200802415A1
(ru)
|
2006-06-09 |
2009-06-30 |
Икос Корпорейшн |
Замещенные фенилуксусные кислоты в качестве dp-2-антагонистов
|
|
GB0612416D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612437D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612435D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612425D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612420D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
UA94615C2
(uk)
*
|
2006-06-28 |
2011-05-25 |
Амген Інк. |
Інгібітори транспортера-1 гліцину
|
|
NZ573129A
(en)
|
2006-06-28 |
2011-06-30 |
Amgen Inc |
Piperazine acetic acid glycine transporter-1 inhibitors
|
|
EP2592070B1
(en)
*
|
2006-06-29 |
2016-08-31 |
F. Hoffmann-La Roche AG |
Tetrazole-substituted arylamides
|
|
JP2008013527A
(ja)
|
2006-07-10 |
2008-01-24 |
Sankyo Co Ltd |
チエノ［３，２−ｄ］ピリミジン−２，４−ジアミン誘導体
|
|
DE102006033114A1
(de)
|
2006-07-18 |
2008-01-24 |
Grünenthal GmbH |
Spirocyclische Azaindol-Derivate
|
|
WO2008034736A2
(en)
|
2006-09-21 |
2008-03-27 |
F. Hoffmann-La Roche Ag |
Oxindole derivatives as anticancer agents
|
|
GB0621607D0
(en)
|
2006-10-31 |
2006-12-06 |
Chroma Therapeutics Ltd |
Inhibitors of c-Met
|
|
PE20080931A1
(es)
|
2006-11-08 |
2008-07-19 |
Schering Corp |
Imidazopirazinas como inhibidores de proteina quinasa
|
|
EP2091927B1
(en)
*
|
2006-11-09 |
2011-07-20 |
F. Hoffmann-La Roche AG |
Thiazole and oxazole-substituted arylamides
|
|
US20080153810A1
(en)
|
2006-11-15 |
2008-06-26 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
KR20080045537A
(ko)
|
2006-11-20 |
2008-05-23 |
에스케이케미칼주식회사 |
피리딘 화합물을 포함하는 간염 치료 및 예방 또는 간 보호효능을 갖는 약제 조성물
|
|
EP2123637A4
(en)
|
2006-11-30 |
2011-12-21 |
Tokyo Inst Tech |
NEW CURCUMIN DERIVATIVES
|
|
CA2672212A1
(en)
|
2006-12-11 |
2008-06-19 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
DE102006060598A1
(de)
|
2006-12-21 |
2008-06-26 |
Merck Patent Gmbh |
Tetrahydrobenzoisoxazole
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
CA2677656A1
(en)
|
2007-02-07 |
2008-08-14 |
Wyeth |
Method for preparing halogenated amines
|
|
US20100216992A1
(en)
|
2007-02-27 |
2010-08-26 |
University Of South Florida |
Mimetic compositions and the production thereof
|
|
CN101631787A
(zh)
|
2007-03-13 |
2010-01-20 |
比奥维特罗姆上市公司 |
用于肥胖症治疗的三环异喹啉衍生物
|
|
PE20090188A1
(es)
|
2007-03-15 |
2009-03-20 |
Novartis Ag |
Compuestos heterociclicos como moduladores de la senda de hedgehog
|
|
CA2683557C
(en)
|
2007-04-09 |
2016-10-18 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
JP2008266236A
(ja)
|
2007-04-23 |
2008-11-06 |
Kyorin Pharmaceut Co Ltd |
環状アミン誘導体又はその塩
|
|
GB0709031D0
(en)
|
2007-05-10 |
2007-06-20 |
Sareum Ltd |
Pharmaceutical compounds
|
|
CA2687931C
(en)
|
2007-05-31 |
2016-05-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists and uses thereof
|
|
JP2010208945A
(ja)
|
2007-06-01 |
2010-09-24 |
Mitsubishi Tanabe Pharma Corp |
複素環化合物
|
|
JP2010530397A
(ja)
|
2007-06-20 |
2010-09-09 |
グラクソ グループ リミテッド |
アミド形成の改善方法
|
|
US7842696B2
(en)
*
|
2007-06-21 |
2010-11-30 |
Forest Laboratories Holdings Limited |
Piperazine derivatives as inhibitors of stearoyl-CoA desaturase
|
|
US20100286160A1
(en)
|
2007-06-28 |
2010-11-11 |
Intervet Inc. |
Substituted piperazines as cb1 antagonists
|
|
JP2010531360A
(ja)
|
2007-06-28 |
2010-09-24 |
インターベット インターナショナル ベー． フェー． |
Ｃｂ１拮抗剤としてのピペラジンの使用
|
|
US8623873B2
(en)
|
2007-06-28 |
2014-01-07 |
Intervet Inc. |
Substituted piperazines as CB1 antagonists
|
|
TW200911808A
(en)
|
2007-07-23 |
2009-03-16 |
Astrazeneca Ab |
Novel compounds
|
|
JP5160827B2
(ja)
|
2007-07-25 |
2013-03-13 |
塩野義製薬株式会社 |
グリコペプチド抗生物質誘導体
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
JP5787756B2
(ja)
|
2008-07-04 |
2015-09-30 |
フィリップ マルリエ |
３−ヒドロキシアルカン酸の酵素的脱炭酸によるアルケンの製造法
|
|
AU2011261375B2
(en)
|
2010-06-04 |
2016-09-22 |
Albany Molecular Research, Inc. |
Glycine transporter-1 inhibitors, methods of making them, and uses thereof
|